Organization

Celularity, Inc.

About

As a clinical-stage biotechnology company, Celularity develops allogeneic cryopreserved off-the-shelf placental-derived cell therapies, including therapeutic programs using unmodified natural killer (NK) cells, genetically modified NK cells, T-cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs). These therapeutic programs target indications in cancer, infectious and degenerative diseases.

Overview

Founded 2016
Type Public
Location Florham Park, New Jersey, USA

Stock

CELU $2.29 -10.55% $(0.27)

Latest News

Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday Sep 22, 2022 Benzinga Gainers Stabilis Solutions, Inc. (NASDAQ: SLNG) shares climbed 71.3% to close at $8.84 after the company announced it has received authorization from the U.S. Department...
Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday Sep 20, 2022 Benzinga Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday. Purple Innovation, Inc. (NASDAQ: PRPL) shares surged 39.4% to...
Wall Street Stock Market Today: Penny Stocks To Watch Before Fed Meeting Sep 20, 2022 PennyStocks What To Watch With 5 Hot Penny Stocks This Week The post Wall Street Stock Market Today: Penny Stocks To Watch Before Fed Meeting appeared...
Celularity Enters Into $150 Million Pre-Paid Advance Agreement with Yorkville Sep 15, 2022 GlobeNewswire Inc. FLORHAM PARK, N.J., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a clinical-stage biotechnology company developing placental-derived allogeneic cell therapies, today announced...
Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session Sep 13, 2022 Benzinga Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis. Akero Therapeutics, Inc. (NASDAQ:...